Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01027416
Title Analyzing a New Mechanism in Response to Tamoxifen Therapy in Breast Cancer Patients
Recruitment Completed
Gender female
Phase Phase I
Variant Requirements Yes
Sponsors Roswell Park Cancer Institute
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Chicago Chicago Illinois 60601 United States Details
Roswell Park Cancer Institute Buffalo New York 14263 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field